Compliance to hypertension guidelines in clinical practice: A multicentre pilot study in Italy

Journal of Human Hypertension

Volumn 16, Issue 10, 2002, Pages 699-703

  Cuspidi, C ^a,b,c   Michev, I ^a,b,c   Lonati, L ^d   Vaccarella, A ^e   Cristofari, M ^f   Garavelli, G ^g   Palumbo, G ^h   Meani, S ^d   Leonetti, G ^d   Magrini, F ^a,b,c   Zanchetti, A ^a,b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d Ospedale S Luca   (Italy)

^e INRCA   (Italy)

^f DESIO HOSPITAL   (Italy)

^g CREMONA HOSPITAL   (Italy)

^h Ospedale di Legnano   (Italy)

Author keywords

Guidelines; Hypertension; Primary care; Risk stratification; Treatment decisions

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; POTASSIUM;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; ELECTROCARDIOGRAM; EYE FUNDUS; FEMALE; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MICROALBUMINURIA; MONOTHERAPY; MULTICENTER STUDY; OUTPATIENT; PATIENT CARE; PATIENT REFERRAL; PHYSICAL EXAMINATION; PILOT STUDY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PROFESSIONAL PRACTICE; QUESTIONNAIRE; RISK ASSESSMENT; TREATMENT PLANNING; URINALYSIS;

CHI-SQUARE DISTRIBUTION; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYPERTENSION; ITALY; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; PRACTICE GUIDELINES; PRIMARY HEALTH CARE; QUESTIONNAIRES; WORLD HEALTH ORGANIZATION;

EID: 0036812519     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001468     Document Type: Article

References (20)

1. MacMahon S et al. Blood pressure, stroke and coronary heart disease, part 1: Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
2. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991; 121: 951-957.
3. He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: An overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J 1999; 138: S211-S219.
4. Collins R et al. Blood pressure, stroke and coronary heart disease, part 2: Short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context. Lancet 1990; 325: 827-838.
5. Hebert PR et al. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993; 153: 578-581.
6. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27: 1214-1218.
7. Hansson L et al. for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1996; 351: 1755-1762.
8. Report of a WHO Expert Committee. Arterial hypertension. In: Technical Report Series 628. Geneva: World Health Organisation, 1978.
9. Guidelines Subcommittee: 1989 Guidelines for the management of mild hypertension: Memorandum from a WHO/ISH meeting. Clin Exp Hyper - Theory Prac 1989; A11: 1203-1216.
10. Zanchetti A, Mancia G. Editor's corner: Debating the value of absolute versus relative risk. J Hypertens 1996; 14: 681.
11. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17: 151-183.
12. Waeber B. Treatment strategy to control blood pressure optimally in hypertensive patients. Blood Pressure 2001; 10: 62-73.
13. Hamilton-Craig CR, Tonkin AL, Jobling RG. How accurate are hypertension treatment decisions? Blood Pressure 2000; 9: 323-327.
14. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.
15. Fahey TP, Peters TJ. What constitutes controlled hypertension? Patient-based comparison of hypertension guidelines. BMJ 1996; 313: 93-96.
16. Dickerson JE, Garrat CJ, Brown MJ. Management of hypertension in general practice: Agreements with and variations from the British Hypertension Society guidelines. J Hum Hypertens 1995; 9: 835-839.
17. Ogden LG, He J, Lydick E, Whelton PK. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to JNC VI risk stratification. Hypertension 2000; 35: 539-543.
18. Hyman DJ, Pavlik VA. Self-reported hypertension treatment practices among primary care physicians. Arch Intern Med 2000; 160: 2281-2286.
19. Hagemeister J et al. Hypertension guidelines and their limitations. The impact of physicians' compliance as evaluated by guidelins awareness. J Hypertens 2001; 19: 2079-2086.
20. Cuspidi C et al. Awareness of hypertension guidelines in general practice: A pilot study in Lombardy. Ital Heart J 2002; 3: 60-63.